4.4 Article

Myeloperoxidase Production by Macrophage and Risk of Atherosclerosis

Journal

CURRENT ATHEROSCLEROSIS REPORTS
Volume 14, Issue 3, Pages 277-283

Publisher

CURRENT MEDICINE GROUP
DOI: 10.1007/s11883-012-0242-3

Keywords

Myeloperoxidase; Acute coronary syndrome; Cardiovascular disease; Atherogenesis

Ask authors/readers for more resources

Myeloperoxidase (MPO), a member of the heme peroxidase superfamily, is a leukocyte-derived enzyme that generates reactive intermediates, leading to oxidative damage of host lipids and proteins. It has been shown that MPO is present within atherosclerotic plaque in human arteries and contributes to atherogenesis by catalyzing oxidative reactions in the vascular wall. This review provides an overview of the analytical and pathophysiologic characteristics of MPO and summarizes the possible clinical applicability of MPO as a marker for diagnosis of acute coronary syndrome and a marker for prediction of cardiovascular disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available